Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action

KA Sacksteder, M Protopopova, CE Barry… - Future …, 2012 - Future Medicine
Existing drugs have limited efficacy against the rising threat of drug-resistant TB, have
significant side effects, and must be given in combinations of four to six drugs for at least 6 …

Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.

KA Sacksteder, M Protopopova, CE Barry 3rd… - Future …, 2012 - europepmc.org
Existing drugs have limited efficacy against the rising threat of drug-resistant TB, have
significant side effects, and must be given in combinations of four to six drugs for at least 6 …

Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action

KA Sacksteder, M Protopopova, CE Barry… - Future …, 2012 - search.proquest.com
Existing drugs have limited efficacy against the rising threat of drug-resistant TB, have
significant side effects, and must be given in combinations of four to six drugs for at least 6 …

Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action

KA Sacksteder, M Protopopova, CE Barry… - Future …, 2012 - cir.nii.ac.jp
抄録< jats: p> Existing drugs have limited efficacy against the rising threat of drug-resistant
TB, have significant side effects, and must be given in combinations of four to six drugs for at …

[HTML][HTML] Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action

KA Sacksteder, M Protopopova, CE Barry 3rd… - Future …, 2012 - ncbi.nlm.nih.gov
Existing drugs have limited efficacy against the rising threat of drug-resistant TB, have
significant side effects, and must be given in combinations of four to six drugs for at least 6 …

Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action

KA Sacksteder, M Protopopova… - Future …, 2012 - pubmed.ncbi.nlm.nih.gov
Existing drugs have limited efficacy against the rising threat of drug-resistant TB, have
significant side effects, and must be given in combinations of four to six drugs for at least 6 …

[PDF][PDF] Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action

CA Nacy - Future Microbiol, 2012 - researchgate.net
Existing drugs have limited efficacy against the rising threat of drug-resistant TB, have
significant side effects, and must be given in combinations of four to six drugs for at least 6 …

[PDF][PDF] Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action

CA Nacy - Future Microbiol, 2012 - academia.edu
Existing drugs have limited efficacy against the rising threat of drug-resistant TB, have
significant side effects, and must be given in combinations of four to six drugs for at least 6 …

Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.

KA Sacksteder, M Protopopova, CE Barry 3rd… - Future …, 2012 - europepmc.org
Existing drugs have limited efficacy against the rising threat of drug-resistant TB, have
significant side effects, and must be given in combinations of four to six drugs for at least 6 …